AELIS: Two important readouts expected after the 2024 summer break
Aelis reported its FY 2023 financial results which highlighted the progress made on its two clinical programs, namely i) after the completion of recruitment of the phase 2b trial of AEF0117 earlier this year, we are expecting a data readout after the summer break, and ii) recruitment of the phase 1
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.